| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 947 | 2022 |
| Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum A Tuekprakhon, R Nutalai, A Dijokaite-Guraliuc, D Zhou, HM Ginn, ... Cell 185 (14), 2422-2433. e13, 2022 | 625 | 2022 |
| Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine RP Payne, S Longet, JA Austin, DT Skelly, W Dejnirattisai, S Adele, ... Cell 184 (23), 5699-5714. e11, 2021 | 278 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial J Frater, KJ Ewer, A Ogbe, M Pace, S Adele, E Adland, J Alagaratnam, ... The lancet HIV 8 (8), e474-e485, 2021 | 225 | 2021 |
| T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study A Angyal, S Longet, SC Moore, RP Payne, A Harding, T Tipton, ... The Lancet Microbe 3 (1), e21-e31, 2022 | 176 | 2022 |
| Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern DT Skelly, AC Harding, J Gilbert-Jaramillo, ML Knight, S Longet, A Brown, ... Nature communications 12 (1), 5061, 2021 | 161 | 2021 |
| Potent cross-reactive antibodies following Omicron breakthrough in vaccinees R Nutalai, D Zhou, A Tuekprakhon, HM Ginn, P Supasa, C Liu, J Huo, ... Cell 185 (12), 2116-2131. e18, 2022 | 129 | 2022 |
| COVID-19 mortality and progress toward vaccinating older adults—World Health Organization, worldwide, 2020–2022 MK Wong MMWR. Morbidity and mortality weekly report 72, 2023 | 56 | 2023 |
| Vaccine-induced immunity provides more robust heterotypic immunity than natural infection to emerging SARS-CoV-2 variants of concern. DT Skelly, AC Harding, J Gilbert-Jaramillo, ML Knight, S Longet, A Brown, ... | 51 | 2021 |
| A delicate balance between antibody evasion and ACE2 affinity for Omicron BA. 2.75 J Huo, A Dijokaite-Guraliuc, C Liu, D Zhou, HM Ginn, R Das, P Supasa, ... Cell reports 42 (1), 2023 | 41 | 2023 |
| Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV A Ogbe, M Pace, M Bittaye, T Tipoe, S Adele, J Alagaratnam, PK Aley, ... JCI insight 7 (7), 2022 | 34 | 2022 |
| Sustained T cell immunity, protection and boosting using extended dosing intervals of BNT162b2 mRNA vaccine RP Payne, S Longet, JA Austin, D Skelly, W Dejnirattisai, S Adele, ... | 22 | 2021 |
| Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens SC Moore, B Kronsteiner, S Longet, S Adele, AS Deeks, C Liu, ... Med 4 (3), 191-215. e9, 2023 | 19 | 2023 |
| Booster vaccination against SARS-CoV-2 induces potent immune responses in people with human immunodeficiency virus S Fidler, J Fox, T Tipoe, S Longet, T Tipton, M Abeywickrema, S Adele, ... Clinical Infectious Diseases 76 (2), 201-209, 2023 | 17 | 2023 |
| Impaired humoral and cellular response to primary COVID‐19 vaccination in patients less than 2 years after allogeneic bone marrow transplant SM Murray, M Barbanti, C Campbell, A Brown, L Chen, J Dhanapal, ... British Journal of Haematology 198 (4), 668-679, 2022 | 17 | 2022 |
| Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination SA Johnson, E Phillips, S Adele, S Longet, T Malone, C Mason, L Stafford, ... Clinical and Experimental Immunology 212 (3), 249-261, 2023 | 13 | 2023 |
| Comparison of two T-cell assays to evaluate T-cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workers E Phillips, S Adele, T Malone, A Deeks, L Stafford, SL Dobson, A Amini, ... Clinical and Experimental Immunology 209 (1), 90-98, 2022 | 9 | 2022 |
| Evolution of long-term hybrid immunity in healthcare workers after different COVID-19 vaccination regimens: a longitudinal observational cohort study SC Moore, B Kronsteiner, S Longet, S Adele, AS Deeks, C Liu, ... MedRxiv, 2022.06. 06.22275865, 2022 | 8 | 2022 |
| The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions. ARD McLean, S Rashan, L Tran, L Arena, AA Lawal, BJ Maguire, S Adele, ... Wellcome Open Research 7 (24), 24, 2022 | 8 | 2022 |
| Safety and immunogenicity of the ChAdox1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection J Frater, K Ewer, A Ogbe, M Pace, S Adele, E Adland, J Alagaratnam, ... | 7 | 2021 |
